Paracetamol (Elderly)
Brand names: Panadol, Calpol
Paracetamol (in older people) is a simple analgesic and antipyretic and is the recommended first-line option for mild-to-moderate pain in this group.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Its analgesic and antipyretic actions are thought to involve central inhibition of prostaglandin synthesis and modulation of pain pathways, with little peripheral anti-inflammatory effect.
Prescribing in practice
- In frail, low-body-weight or chronically malnourished older people, and in those with hepatic impairment or chronic high alcohol intake, a reduced total daily dose may be appropriate to limit hepatotoxicity risk.
- Account for paracetamol contained in combination analgesics and over-the-counter products to avoid inadvertent excess.
- It is preferred over NSAIDs in older people because it avoids gastrointestinal, renal and cardiovascular NSAID hazards.
Monitoring
Routine monitoring is not required, but review cumulative intake and consider hepatic status in frail or low-weight older patients.
Counselling the patient
- Do not take other products that also contain paracetamol at the same time.
- Take regularly rather than only when pain is severe for steadier control.
Evidence & guidelines
NICE guidance positions paracetamol as a first-line analgesic, and it is generally favoured over NSAIDs in older adults because of its safer organ profile.
Reference: AGS guidelines; NICE NG193; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- SCORE2-OP — 5/10-Year CVD Risk (Age ≥ 70) · Cardiovascular Risk
- Rumack-Matthew Nomogram · Toxicology
- Numeric Rating Scale (NRS) Pain Assessment and Management · Pain Management
- Hearing Handicap Inventory for the Elderly — Screening (HHIE-S) · Hearing
- Clinical Frailty Scale (CFS) · Prognosis
- Confusion Assessment Method (CAM) · Cognitive Assessment
- Falls Assessment in Older Adults · NICE CG161 2013
- Delirium Outside ICU · NICE CG103
- Comprehensive Geriatric Assessment (CGA) · BGS / NICE
- Delirium Assessment and Management · NICE CG103 2010
- Frailty Recognition and Management · BGS Frailty Framework / NHS NHSE
- Polypharmacy and Medicines Optimisation · STOPP/START v2 2014 / NICE NG5